10170 CHURCH RANCH WAY, WESTMINSTER, CO
Certain Financial and Operating Data for First Quarter
Reg. FD, Other Events
Annual Report to Security Holders
Director Resignation and Appointment at Oruka Therapeutics
Announces Positive Interim Phase 1 Results for ORKA-001
News, Material Contracts
Shareholder votes
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Prospectus filed pursuant to Rule 424(b)(7)